for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Becton Dickinson and Co

BDX.N

Latest Trade

240.28USD

Change

-0.81(-0.34%)

Volume

253,541

Today's Range

239.36

 - 

242.62

52 Week Range

197.75

 - 

286.67

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
241.09
Open
240.84
Volume
253,541
3M AVG Volume
30.49
Today's High
242.62
Today's Low
239.36
52 Week High
286.67
52 Week Low
197.75
Shares Out (MIL)
289.87
Market Cap (MIL)
69,649.62
Forward P/E
--
Dividend (Yield %)
1.32

Next Event

Q4 2020 Becton Dickinson and Co Earnings Call

Latest Developments

More

Bd Granted FDA 510K Clearance For Bd Facslyric Flow Cytometer With Newly Integrated Bd Facsduet Sample Preparation System

Bd Announces FDA Classifications For August 4Th Recalls Of BD Alaris System

BD Provides Update On Previously Disclosed Recall Of BD Alaris System Hardware

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Becton Dickinson and Co

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.

Industry

Medical Equipment & Supplies

Contact Info

1 Becton Dr

FRANKLIN LAKES, NJ

07417-1815

United States

+1.201.8476800

http://www.bd.com/

Executive Leadership

Vincent A. Forlenza

Executive Chairman of the Board

Thomas E. Polen

President, Chief Executive Officer, Chief Operating Officer, Director

Christopher R. Reidy

Chief Financial Officer, Executive Vice President, Chief Administrative Officer

Betty D. Larson

Executive Vice President- Human Resources, Chief Human Resources

Samrat S. Khichi

Executive Vice President, General Counsel

Key Stats

2.06 mean rating - 17 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

12.1K

2018

16.0K

2019

17.3K

2020(E)

16.8K
EPS (USD)

2017

9.480

2018

11.010

2019

11.680

2020(E)

9.935
Price To Earnings (TTM)
84.62
Price To Sales (TTM)
4.12
Price To Book (MRQ)
2.90
Price To Cash Flow (TTM)
23.67
Total Debt To Equity (MRQ)
77.93
LT Debt To Equity (MRQ)
71.14
Return on Investment (TTM)
1.94
Return on Equity (TTM)
1.72

Latest News

Latest News

UPDATE 1-Nevada's ban on Quidel and Becton Dickinson COVID-19 tests violates law -HHS official

Nevada's recent ban on the use of Quidel Corp's Sofia and Becton Dickinson and Co's Veritor point-of-care antigen tests for COVID-19 in long-term care facilities violates federal law, a U.S. government official said on Friday.

Nevada's prohibition of Quidel, Becton Dickinson's COVID-19 tests violates law: HHS official

U.S. state of Nevada's recent ban on the use of Quidel Corp's Sofia and Becton Dickinson and Co's (BD) Veritor point of care antigen tests in long-term care facilities violates federal law, a U.S. government official said on Friday.

Becton Dickinson says COVID-19 test kit meets requirements for Europe launch

U.S. medical device maker Becton Dickinson and Co said on Wednesday its COVID-19 antigen test kit met the requirements for a launch in Europe.

Becton Dickinson reaches $60 million settlement over pelvic mesh devices

Becton Dickinson and Co <BDX.N> agreed to pay $60 million to resolve allegations by the attorneys general of 48 U.S. states and Washington D.C. that its CR Bard unit concealed the risks of its now-discontinued transvaginal pelvic mesh devices.

Becton Dickinson reaches $60 million settlement over pelvic mesh products

Becton Dickinson and Co said on Thursday it has reached a $60 million settlement with the attorneys general of 48 U.S. states and Washington, D.C. to settle litigation related to discontinued pelvic mesh products.

Becton Dickinson reaches $60 mln settlement over pelvic mesh products

Becton Dickinson and Co said on Thursday it has reached a $60 million settlement with the attorneys general of 48 U.S. states and Washington, D.C. to settle litigation related to discontinued pelvic mesh products.

NY sues Becton Dickinson unit over surgical mesh devices, consent judgment expected

New York's attorney general on Thursday filed a lawsuit accusing Becton Dickinson and Co's CR Bard unit of concealing the risks of surgical mesh devices.

Becton Dickinson probes false-positive COVID-19 test results in U.S. nursing homes

Becton Dickinson said on Tuesday it is investigating reports from U.S. nursing homes that its rapid coronavirus testing equipment is producing false-positive results.

Becton on track to make one billion syringes to help COVID-19 vaccination

Becton Dickinson and Co <BDX.N> said on Thursday it was on track to make 1 billion syringes in the next 12-18 months to meet demand for COVID-19 vaccination when approved, as the medical device maker reported quarterly revenue below estimates, sending its shares down nearly...

Becton Dickinson on track to produce one billion syringes in 12-18 months

Medical device maker Becton Dickinson and Co said on Thursday it would be able to produce 1 billion syringes in the next 12-18 months.

Becton Dickinson profit slumps nearly 37% on delayed surgeries

Medical technology company Becton Dickinson and Co on Thursday reported a 36.6% fall in quarterly profit, hurt by lower demand for its devices as people delayed non-urgent surgeries during the COVID-19 pandemic.

U.S. government agrees to buy Becton's COVID-19 testing devices

The U.S. government will buy Becton, Dickinson and Co's COVID-19 testing devices and kits, the company said on Wednesday, as it ramps up its testing for the virus that has been spreading at an alarming rate.

U.S. govt to invest $42 million in Becton Dickinson to ramp up vaccination efforts

Becton Dickinson and Co <BDX.N> said on Wednesday the U.S. government will invest $42 million to expand the medical technology company's manufacturing capacity for syringes and needles to support vaccination efforts against COVID-19.

U.S. govt to invest $42 mln in Becton Dickinson's injection device production

Becton Dickinson and Co said on Wednesday the U.S. government will invest $42 million to expand the medical technology company's manufacturing lines for injection devices to support vaccination efforts against COVID-19.

BRIEF-BD Launches First And Only Fully Sterile Povidone-Iodine And Isopropyl Alcohol Skin Preparation

* BD LAUNCHES FIRST AND ONLY FULLY STERILE POVIDONE-IODINE AND ISOPROPYL ALCOHOL SKIN PREPARATION

U.S. FDA alerts on false positive result from Becton Dickinson COVID-19 test

The U.S. Food and Drug Administration alerted clinical laboratories and healthcare providers on Monday about false positive results from one of Becton Dickinson and Co's COVID-19 molecular diagnostic tests.

Becton Dickinson's rapid antigen test for COVID-19 authorized by FDA, shares rise

The U.S. Food and Drug Administration has granted emergency use authorization to Becton Dickinson and Co <BDX.N> for a COVID-19 antigen test that can be administered at the point of care and produce results within 15 minutes, the company said on Monday.

UPDATE 1-Becton Dickinson's rapid antigen test for COVID-19 authorized by FDA, shares rise

The U.S. Food and Drug Administration has granted emergency use authorization to Becton Dickinson and Co for a COVID-19 antigen test that can be administered at the point of care and produce results within 15 minutes, the company said on Monday.

UK orders 65 million injection devices from Becton Dickinson for vaccine program

Medical technology company Becton Dickinson and Co said on Friday it received an order from the UK government for 65 million injection devices to support Britain's COVID-19 vaccination program.

BRIEF-BD Prices Offerings Of $1.5 Bln Of Common Stock And $1.5 Bln Of Depositary Shares

* BD PRICES OFFERINGS OF $1.5 BILLION OF COMMON STOCK AND $1.5 BILLION OF DEPOSITARY SHARES REPRESENTING INTERESTS IN MANDATORY CONVERTIBLE PREFERRED STOCK

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up